Stay updated on aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    13 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.
    Difference
    4%
    Check dated 2025-10-05T05:11:53.000Z thumbnail image
  2. Check
    20 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T02:50:25.000Z thumbnail image
  3. Check
    27 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; 'Back to Top' link removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:36:45.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T14:59:22.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new treatment modalities such as Chemoradiotherapy and Combined Modality Therapy, while removing specific terms related to neoplasms and immunological agents, including the drug pembrolizumab.
    Difference
    3%
    Check dated 2025-08-30T11:46:15.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:34:50.000Z thumbnail image

Stay in the know with updates to aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.